Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Syndax Pharma (SNDX)

Syndax Pharma (SNDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Syndax Pharma 35 GATEHOUSE DRIVE BUILDING D FLOOR 3 WALTHAM MA 02451 USA

www.syndax.com P: 781-419-1400 F: 781-419-1420

Description:

Syndax Pharmaceuticals, Inc. is a biopharmaceutical company which focused on the development and commercialization of entinostat, an epigenetic therapy for treatment-resistant cancers. The Company's product pipeline includes ENCORE 601, ENCORE 602, J1353, NCI-7870, NCI-9844, E2112, NCI-8871 and NCI-9253 which are in clinical trial stage. Syndax Pharmaceuticals, Inc. is based in WALTHAM, United States.

Key Statistics

Overview:

Market Capitalization, $K 1,781,716
Enterprise Value, $K 1,486,326
Shares Outstanding, K 84,965
Annual Sales, $ 0 K
Annual Net Income, $ -209,360 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -72,470 K
EBIT, $ -229,970 K
EBITDA, $ -244,760 K
60-Month Beta 1.03
% of Insider Shareholders 4.10%
Float, K 81,481
% Float 95.90%
Short Volume Ratio 0.54

Growth:

1-Year Return -2.30%
3-Year Return 30.43%
5-Year Return 190.36%
5-Year Revenue Growth -100.00%
5-Year Earnings Growth -2.05%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -1.00 on 02/27/24
Latest Earnings Date 05/13/24
Earnings Per Share ttm -2.96
EPS Growth vs. Prev Qtr -36.99%
EPS Growth vs. Prev Year -61.29%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

SNDX Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -47.88%
Return-on-Assets % -44.00%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 3.18
Book Value/Share 6.53
Interest Coverage -995.95
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar